2004. The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland - an analysis of the RENAAL study. Swiss Medical Weekly. 134, 3132 (Aug. 2004), 440–447. DOI:https://doi.org/10.4414/smw.2004.10492.